These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32679305)

  • 1. Dose-volume effects of breast cancer radiation therapy on the risk of second oesophageal cancer.
    Journy N; Schonfeld SJ; Hauptmann M; Roberti S; Howell RM; Smith SA; Vaalavirta L; Stovall M; van Leeuwen FE; Weathers RE; Hodgson D; Gilbert ES; Berrington de Gonzalez A; Morton LM
    Radiother Oncol; 2020 Oct; 151():33-39. PubMed ID: 32679305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy-Related Dose and Irradiated Volume Effects on Breast Cancer Risk Among Hodgkin Lymphoma Survivors.
    Roberti S; van Leeuwen FE; Ronckers CM; Krul IM; de Vathaire F; Veres C; Diallo I; Janus CPM; Aleman BMP; Russell NS; Hauptmann M
    J Natl Cancer Inst; 2022 Sep; 114(9):1270-1278. PubMed ID: 35771630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of cardiac doses received during chemoradiation of oesophageal and gastro-oesophageal junctional cancers.
    Mukherjee S; Aston D; Minett M; Brewster AE; Crosby TD
    Clin Oncol (R Coll Radiol); 2003 May; 15(3):115-20. PubMed ID: 12801047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy.
    Willner J; Jost A; Baier K; Flentje M
    Strahlenther Onkol; 2003 Aug; 179(8):548-56. PubMed ID: 14509954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure of the oesophagus in breast cancer radiotherapy: A systematic review of oesophagus doses published 2010-2020.
    Duane FK; Kerr A; Wang Z; Darby SC; Ntentas G; Aznar MC; Taylor CW
    Radiother Oncol; 2021 Nov; 164():261-267. PubMed ID: 34626725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms.
    Jackson A; Skwarchuk MW; Zelefsky MJ; Cowen DM; Venkatraman ES; Levegrun S; Burman CM; Kutcher GJ; Fuks Z; Liebel SA; Ling CC
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):685-98. PubMed ID: 11172950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second cancer after radiotherapy, 1981-2007.
    Bartkowiak D; Humble N; Suhr P; Hagg J; Mair K; Polivka B; Schneider U; Bottke D; Wiegel T
    Radiother Oncol; 2012 Oct; 105(1):122-6. PubMed ID: 21993405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric evaluation of conventional radiotherapy, 3-D conformal radiotherapy and direct machine parameter optimisation intensity-modulated radiotherapy for breast cancer after conservative surgery.
    Zhang F; Zheng M
    J Med Imaging Radiat Oncol; 2011 Dec; 55(6):595-602. PubMed ID: 22141607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.
    Piotrowski T; Matecka-Nowak M; Milecki P
    Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?
    Nitsche M; Brannath W; Brückner M; Wagner D; Kaltenborn A; Temme N; Hermann RM
    Br J Radiol; 2017 Feb; 90(1070):20160370. PubMed ID: 27936891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of treatment-related esophageal cancer among breast cancer survivors.
    Morton LM; Gilbert ES; Hall P; Andersson M; Joensuu H; Vaalavirta L; Dores GM; Stovall M; Holowaty EJ; Lynch CF; Curtis RE; Smith SA; Kleinerman RA; Kaijser M; Storm HH; Pukkala E; Weathers RE; Linet MS; Rajaraman P; Fraumeni JF; Brown LM; van Leeuwen FE; Fossa SD; Johannesen TB; Langmark F; Lamart S; Travis LB; Aleman BMP
    Ann Oncol; 2012 Dec; 23(12):3081-3091. PubMed ID: 22745217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.
    Wang SL; Liao Z; Vaporciyan AA; Tucker SL; Liu H; Wei X; Swisher S; Ajani JA; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):692-9. PubMed ID: 16242257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation Dose-Response for Risk of Myocardial Infarction in Breast Cancer Survivors.
    Jacobse JN; Duane FK; Boekel NB; Schaapveld M; Hauptmann M; Hooning MJ; Seynaeve CM; Baaijens MHA; Gietema JA; Darby SC; van Leeuwen FE; Aleman BMP; Taylor CW
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):595-604. PubMed ID: 30385276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rectal sequelae after conformal radiotherapy of prostate cancer: dose-volume histograms as predictive factors.
    Wachter S; Gerstner N; Goldner G; Pötzi R; Wambersie A; Pötter R
    Radiother Oncol; 2001 Apr; 59(1):65-70. PubMed ID: 11295208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification and reduction of cardiac dose in radical radiotherapy for oesophageal cancer.
    Cominos M; Mosleh-Shirazi MA; Tait D; Henrys A; Cornes P
    Br J Radiol; 2005 Dec; 78(936):1069-74. PubMed ID: 16352580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase II Toxicity End Point Trial (ICORG 99-09) of Accelerated Dose-escalated Hypofractionated Radiation in Non-small Cell Lung Cancer.
    Cagney DN; Thirion PG; Dunne MT; Fleming C; Fitzpatrick D; O'Shea CM; Finn MA; O'Sullivan S; Booth C; Collins CD; Buckney SJ; Shannon A; Armstrong JG
    Clin Oncol (R Coll Radiol); 2018 Jan; 30(1):30-38. PubMed ID: 29097074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Low dose volume histogram analysis of the lungs in prediction of acute radiation pneumonitis in patients with esophageal cancer treated with three-dimensional conformal radiotherapy].
    Shen WB; Zhu SC; Gao HM; Li YM; Liu ZK; Li J; Su JW; Wan J
    Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):45-9. PubMed ID: 23648300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quantitative treatment planning study evaluating the potential of dose escalation in conformal radiotherapy of the oesophagus.
    Bedford JL; Viviers L; Guzel Z; Childs PJ; Webb S; Tait DM
    Radiother Oncol; 2000 Nov; 57(2):183-93. PubMed ID: 11054522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-volume analysis for quality assurance of interstitial brachytherapy for breast cancer.
    Vicini FA; Kestin LL; Edmundson GK; Jaffray DA; Wong JW; Kini VR; Chen PY; Martinez AA
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):803-10. PubMed ID: 10524437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6-70.2 Gy).
    Cozzarini C; Fiorino C; Ceresoli GL; Cattaneo GM; Bolognesi A; Calandrino R; Villa E
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):688-94. PubMed ID: 12573756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.